IDO2: A Pathogenic Mediator of Inflammatory Autoimmunity

por Merlo, Lauren M.F., Mandik-Nayak, Laura
Publicado 2016

Impact of IDO1 and IDO2 on the B Cell Immune Response

por Merlo, Lauren M. F., Peng, Weidan, Mandik-Nayak, Laura
Publicado 2022

IDO2 in Immunomodulation and Autoimmune Disease

por Prendergast, George C., Metz, Richard, Muller, Alexander J., Merlo, Lauren M. F., Mandik-Nayak, Laura
Publicado 2014

Application of simultaneous selective pressures slows adaptation

por Merlo, Lauren M. F., Sprouffske, Kathleen, Howard, Taylor C., Gardiner, Kristin L., Caulin, Aleah F., Blum, Steven M., Evans, Perry, Bedalov, Antonio, Sniegowski, Paul D., Maley, Carlo C.
Publicado 2020

Differential Roles of IDO1 and IDO2 in T and B Cell Inflammatory Immune Responses

por Merlo, Lauren M. F., DuHadaway, James B., Montgomery, James D., Peng, Wei-Dan, Murray, Peter J., Prendergast, George C., Caton, Andrew J., Muller, Alexander J., Mandik-Nayak, Laura
Publicado 2020

Peptide vaccination directed against IDO1-expressing immune cells elicits CD8(+) and CD4(+) T-cell-mediated antitumor immunity and enhanced anti-PD1 responses

por Dey, Souvik, Sutanto-Ward, Erika, Kopp, Katharina L, DuHadaway, James, Mondal, Arpita, Ghaban, Dema, Lecoq, Inés, Zocca, Mai-Britt, Merlo, Lauren M F, Mandik-Nayak, Laura, Andersen, Mads Hald, Pedersen, Ayako Wakatsuki, Muller, Alexander J
Publicado 2020